BNB Climbs Back to $780 as Windtree Commits $520M to Token Treasury
BNB recovered from a sharp dip on Saturday, climbing to near $780 after biopharma firm Windtree Therapeutics disclosed a $520 million investment into the token as part of its corporate treasury holdings.
The move sparked renewed interest in BNB, which had recently fallen to $761.22 during a period of intensified trading activity. The token quickly reversed course, rallying to an intraday high of $785.75 — a clear V-shaped recovery that helped stabilize price action above the key $761 support zone.
According to CoinDesk Research, the sharp correction earlier in the session saw BNB drop from $774.52 to $761.34 on volume exceeding twice its 24-hour average. However, the Windtree news shifted sentiment, with the market viewing the large-scale allocation as a major vote of confidence in BNB from a traditional company.
The $520 million commitment ranks among the largest non-Bitcoin corporate treasury investments in the crypto space. Other firms, including Nano Labs, have also taken positions in BNB, which continues to benefit from deflationary tailwinds through routine token burns by Binance and BNB Chain.
The broader BNB ecosystem is also expanding. BNB Chain recently launched the latest round of its Most Valuable Builder program, supporting 15 early-stage projects focused on AI, DeFi, and tokenized real-world assets — all of which reinforce the platform’s long-term utility and developer engagement.
With price action now consolidating near $780, analysts say BNB could be setting up for a broader move higher, assuming support levels hold and institutional interest continues to build.
